BRCA1 and neoplasm: More and more tumor biomarkers, such as PD-L1, BRCA1/2, BRAF, HER2, etc., have been discovered, which become an indispensable tool in current tumor treatment due to its ability to assist various clinical decisions (Zhou et al., 2015).